Canaccord Genuity Keeps Rating And Raises Price Target On Stryker Corporation (SYK) – Modern Readers

Posted: August 25, 2017 at 4:13 am

Advertisement

Stryker Corporation (NYSE:SYK).

On June 30 analysts at Cantor Fitzgerald starting coverage on the stock giving it an initial rating of Neutral. On May 16, 2017 Goldman Sachs released its first research report on the stock by announcing an initial rating of Neutral.

In the market the company is trading down by -0.12% since yesterdays close of $138.36. Additionally the company recently declared a dividend which will be paid on Tuesday the 31st of October 2017. The dividend will be $0.425 per share for the quarter which is $1.70 annualized. The dividend yield will be $1.17. The ex-dividend date will be on Wednesday the 28th of June 2017.

The stock last traded at $138.19 which is marginally lower than the 50 day moving average of $144.81 and which is slightly above the 200 day moving average of $136.90. The 50 day moving average was down by -4.54% and the 200 day average went up $1.34 or +0.98%.

Stryker Corporation (Stryker), launched on February 20, 1946, is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Businesss segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The Businesss MedSurg segment consists of instruments, endoscopy, medical and sustainability products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products..

Stryker Corporations P/E ratio is 30.86 and market capitalization is 51.71B. As of the last earnings report the EPS was $4.48 and is projected to be $6.50 for the current year with 374,063,000 shares outstanding. Analysts expect next quarters EPS to be $1.95 with next years EPS anticipated to be $7.11.

Originally posted here:

Canaccord Genuity Keeps Rating And Raises Price Target On Stryker Corporation (SYK) - Modern Readers

Related Post